Ma Y - Search Results

1

Theranostic nanoemulsions: codelivery of hydrophobic drug and hydrophilic imaging probe for cancer therapy and imaging.

Yang X, Wang D, Ma Y, Zhao Q, Fallon JK, Liu D, Xu XE, Wang Y, He Z, Liu F. Yang X, et al. Among authors: ma y. Nanomedicine (Lond). 2014 Dec;9(18):2773-85. doi: 10.2217/nnm.14.50. Nanomedicine (Lond). 2014. PMID: 25000945

2

Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer.

Ma Y, Liu D, Wang D, Wang Y, Fu Q, Fallon JK, Yang X, He Z, Liu F. Ma Y, et al. Mol Pharm. 2014 Aug 4;11(8):2623-30. doi: 10.1021/mp400778r. Epub 2014 Apr 21. Mol Pharm. 2014. PMID: 24712391 Free PMC article.

3

Shape-controlled paclitaxel nanoparticles with multiple morphologies: rod-shaped, worm-like, spherical, and fingerprint-like.

Wang Y, Wang D, Fu Q, Liu D, Ma Y, Racette K, He Z, Liu F. Wang Y, et al. Among authors: ma y. Mol Pharm. 2014 Oct 6;11(10):3766-71. doi: 10.1021/mp500436p. Epub 2014 Sep 8. Mol Pharm. 2014. PMID: 25188586 Free PMC article.

4

Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines.

Wang Y, Liu D, Zheng Q, Zhao Q, Zhang H, Ma Y, Fallon JK, Fu Q, Haynes MT, Lin G, Zhang R, Wang D, Yang X, Zhao L, He Z, Liu F. Wang Y, et al. Among authors: ma y. Nano Lett. 2014 Oct 8;14(10):5577-83. doi: 10.1021/nl502044x. Epub 2014 Sep 7. Nano Lett. 2014. PMID: 25188744 Free PMC article.

5

Extreme low dose of 5-fluorouracil reverses MDR in cancer by sensitizing cancer associated fibroblasts and down-regulating P-gp.

Ma Y, Wang Y, Xu Z, Wang Y, Fallon JK, Liu F. Ma Y, et al. PLoS One. 2017 Jun 29;12(6):e0180023. doi: 10.1371/journal.pone.0180023. eCollection 2017. PLoS One. 2017. PMID: 28662182 Free PMC article.

6

New mouse xenograft model modulated by tumor-associated fibroblasts for human multi-drug resistance in cancer.

Ma Y, Lin Z, Fallon JK, Zhao Q, Liu D, Wang Y, Liu F. Ma Y, et al. Oncol Rep. 2015 Nov;34(5):2699-705. doi: 10.3892/or.2015.4265. Epub 2015 Sep 9. Oncol Rep. 2015. PMID: 26352907 Free PMC article.

7

The Effect of Surfactant on Paclitaxel Nanocrystals: An In Vitro and In Vivo Study.

Liu H, Ma Y, Liu D, Fallon JK, Liu F. Liu H, et al. Among authors: ma y. J Biomed Nanotechnol. 2016 Jan;12(1):147-53. doi: 10.1166/jbn.2016.2127. J Biomed Nanotechnol. 2016. PMID: 27301180

8

Paclitaxel-Paclitaxel Prodrug Nanoassembly as a Versatile Nanoplatform for Combinational Cancer Therapy.

Han X, Chen J, Jiang M, Zhang N, Na K, Luo C, Zhang R, Sun M, Lin G, Zhang R, Ma Y, Liu D, Wang Y. Han X, et al. Among authors: ma y. ACS Appl Mater Interfaces. 2016 Dec 14;8(49):33506-33513. doi: 10.1021/acsami.6b13057. Epub 2016 Dec 1. ACS Appl Mater Interfaces. 2016. PMID: 27960378

9

Redox-sensitive prodrug nanoassemblies based on linoleic acid-modified docetaxel to resist breast cancers.

Li M, Zhao L, Zhang T, Shu Y, He Z, Ma Y, Liu D, Wang Y. Li M, et al. Among authors: ma y. Acta Pharm Sin B. 2019 Mar;9(2):421-432. doi: 10.1016/j.apsb.2018.08.008. Epub 2018 Aug 31. Acta Pharm Sin B. 2019. PMID: 30972286 Free PMC article.

10

Reduction-sensitive Paclitaxel Prodrug Self-assembled Nanoparticles with Tetrandrine Effectively Promote Synergistic Therapy Against Drug-sensitive and Multidrug-resistant Breast Cancer.

Jiang M, Zhang R, Wang Y, Jing W, Liu Y, Ma Y, Sun B, Wang M, Chen P, Liu H, He Z. Jiang M, et al. Among authors: ma y. Mol Pharm. 2017 Nov 6;14(11):3628-3635. doi: 10.1021/acs.molpharmaceut.7b00381. Epub 2017 Sep 27. Mol Pharm. 2017. PMID: 28895735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43,380 results

Search Page

Filters